More compact doses for perioral treatment than for upper facial applications are employed as the oral musculature responds much more strongly to precisely the same BTX-A dosing. Only one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA approval lies in treatments of cervical dystonia. https://lanejvdkq.jasperwiki.com/6812422/the_ultimate_guide_to_how_toxic_is_botulinum_toxin